Evonik, one of the world's leading specialty chemicals companies, launched its latest regional animal nutrition innovations at the International Exhibition for the Administration & Production of Poultry & Livestock (AGRENA) that took place earlier in July at the Cairo International Convention and Exhibition Centre.
“Our aim is to be THE reliable partner in delivering feed additives for animal nutrition and to turn the knowledge of our global team into intelligent solutions that create added value for our customers” said Ahmed Khater, Technical Service Manager for Animal Nutrition at Evonik Limited Egypt.
“Our presence in AGRENA today reflects our commitment to the Egyptian market where we have already placed a fully dedicated team of experienced feed industry specialists with high technical competencies” Khater added.
Biolys® and Ecobiol® are Evonik’s latest regional offerings launched at the show. Biolys® is an innovative lysine source characterized by excellent handling and processing properties and a minimum content of 54.6 percent L-lysine in the form of sulfate salt and co-products from the fermentation process which are valuable for nutrition.
Ecobiol®, on the other hand, is a feed additive which consists of a natural fast-growing Bacillus amyloliquefaciens CECT 5940 strain that potentially improves the overall condition of the animals and helps producers to solve quality, profitability and sustainability challenges.
This year, Evonik participated in AGRENA for the 5th consecutive time with an 84 m2 booth. In addition to the launch of Biolys® and Ecobiol®, the company showcased a wide range of products including MetAMINO®, ThreAMINO®, Mepron®, CreAMINO®, ValAMINO®, and DL-Methionine® for aquaculture.
Not only is Evonik the world market leader in the methionine production, it is also the only amino acids supplier that is represented in Egypt since 1964. Moreover, the German based industrial group offers a wide range of unique technical services that support partners in increasing profitability and efficiency.
Evonik is one of the world leaders in specialty chemicals. The focus on more specialty businesses, customer-orientated innovative prowess and a trustful and performance-oriented corporate culture form the heart of Evonik’s corporate strategy. They are the lever for profitable growth and a sustained increase in the value of the company. Evonik benefits specifically from its customer proximity and leading market positions. Evonik is active in over 100 countries around the world with more than 35,000 employees. In fiscal 2016, the enterprise generated sales of around €12.7 billion and an operating profit (adjusted EBITDA) of about €2.165 billion.
In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.